Keywords: celgene, begins, selcid, trial, corp, begun, seven-day

Celgene Begins SelCID Trial

Article | 12 March 1998

Print This

Celgene Corp has begun a seven-day multidose trial of SelCID(selective cytokine inhibitory drug CC801), a small molecule inhibitor of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in